nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.774	1	CbGaD
Diphenhydramine—SLC22A5—Furosemide—dilated cardiomyopathy	0.124	1	CbGbCtD
Diphenhydramine—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00621	0.0749	CcSEcCtD
Diphenhydramine—Drug eruption—Furosemide—dilated cardiomyopathy	0.00338	0.0407	CcSEcCtD
Diphenhydramine—Bepridil—TNNC1—dilated cardiomyopathy	0.00214	0.565	CrCbGaD
Diphenhydramine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00214	0.0258	CcSEcCtD
Diphenhydramine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00199	0.024	CcSEcCtD
Diphenhydramine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00176	0.0213	CcSEcCtD
Diphenhydramine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00175	0.595	CbGeAlD
Diphenhydramine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00172	0.0207	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00167	0.0202	CcSEcCtD
Diphenhydramine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00151	0.0183	CcSEcCtD
Diphenhydramine—Irritability—Furosemide—dilated cardiomyopathy	0.00144	0.0174	CcSEcCtD
Diphenhydramine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00143	0.0173	CcSEcCtD
Diphenhydramine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00137	0.0166	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00133	0.0161	CcSEcCtD
Diphenhydramine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00129	0.0155	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00125	0.0151	CcSEcCtD
Diphenhydramine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00124	0.015	CcSEcCtD
Diphenhydramine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00121	0.0146	CcSEcCtD
Diphenhydramine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.0012	0.0145	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00119	0.0144	CcSEcCtD
Diphenhydramine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00116	0.014	CcSEcCtD
Diphenhydramine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00113	0.0137	CcSEcCtD
Diphenhydramine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00112	0.0135	CcSEcCtD
Diphenhydramine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00108	0.0131	CcSEcCtD
Diphenhydramine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00108	0.0131	CcSEcCtD
Diphenhydramine—Irritability—Lisinopril—dilated cardiomyopathy	0.00108	0.013	CcSEcCtD
Diphenhydramine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000973	0.0117	CcSEcCtD
Diphenhydramine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000952	0.0115	CcSEcCtD
Diphenhydramine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000932	0.0112	CcSEcCtD
Diphenhydramine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000914	0.011	CcSEcCtD
Diphenhydramine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000901	0.0109	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000893	0.0108	CcSEcCtD
Diphenhydramine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000866	0.0105	CcSEcCtD
Diphenhydramine—Rash—Spironolactone—dilated cardiomyopathy	0.000859	0.0104	CcSEcCtD
Diphenhydramine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000858	0.0104	CcSEcCtD
Diphenhydramine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000856	0.0103	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000855	0.0103	CcSEcCtD
Diphenhydramine—Headache—Spironolactone—dilated cardiomyopathy	0.000853	0.0103	CcSEcCtD
Diphenhydramine—Agitation—Furosemide—dilated cardiomyopathy	0.000834	0.0101	CcSEcCtD
Diphenhydramine—Vertigo—Furosemide—dilated cardiomyopathy	0.000816	0.00984	CcSEcCtD
Diphenhydramine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000814	0.00982	CcSEcCtD
Diphenhydramine—Nausea—Spironolactone—dilated cardiomyopathy	0.000809	0.00976	CcSEcCtD
Diphenhydramine—Phenytoin—SCN5A—dilated cardiomyopathy	0.000802	0.212	CrCbGaD
Diphenhydramine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000756	0.00912	CcSEcCtD
Diphenhydramine—Confusional state—Furosemide—dilated cardiomyopathy	0.000747	0.00902	CcSEcCtD
Diphenhydramine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00073	0.00881	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000726	0.00876	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000716	0.00864	CcSEcCtD
Diphenhydramine—Anorexia—Furosemide—dilated cardiomyopathy	0.000706	0.00852	CcSEcCtD
Diphenhydramine—Chills—Lisinopril—dilated cardiomyopathy	0.000702	0.00847	CcSEcCtD
Diphenhydramine—Hypotension—Furosemide—dilated cardiomyopathy	0.000692	0.00836	CcSEcCtD
Diphenhydramine—Tension—Lisinopril—dilated cardiomyopathy	0.000669	0.00807	CcSEcCtD
Diphenhydramine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000665	0.00803	CcSEcCtD
Diphenhydramine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000662	0.00798	CcSEcCtD
Diphenhydramine—Somnolence—Furosemide—dilated cardiomyopathy	0.000659	0.00795	CcSEcCtD
Diphenhydramine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000644	0.00777	CcSEcCtD
Diphenhydramine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000642	0.00775	CcSEcCtD
Diphenhydramine—Fatigue—Furosemide—dilated cardiomyopathy	0.000639	0.00771	CcSEcCtD
Diphenhydramine—Tremor—Lisinopril—dilated cardiomyopathy	0.000638	0.0077	CcSEcCtD
Diphenhydramine—Constipation—Furosemide—dilated cardiomyopathy	0.000634	0.00765	CcSEcCtD
Diphenhydramine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000612	0.00739	CcSEcCtD
Diphenhydramine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000611	0.00737	CcSEcCtD
Diphenhydramine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000602	0.00726	CcSEcCtD
Diphenhydramine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.000594	0.157	CrCbGaD
Diphenhydramine—Urticaria—Furosemide—dilated cardiomyopathy	0.000589	0.0071	CcSEcCtD
Diphenhydramine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000567	0.00685	CcSEcCtD
Diphenhydramine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000561	0.00677	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000544	0.00657	CcSEcCtD
Diphenhydramine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000543	0.00655	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000538	0.00649	CcSEcCtD
Diphenhydramine—Asthenia—Furosemide—dilated cardiomyopathy	0.000532	0.00642	CcSEcCtD
Diphenhydramine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00053	0.0064	CcSEcCtD
Diphenhydramine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00052	0.00627	CcSEcCtD
Diphenhydramine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000507	0.00612	CcSEcCtD
Diphenhydramine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000503	0.00607	CcSEcCtD
Diphenhydramine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000499	0.00602	CcSEcCtD
Diphenhydramine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000494	0.00596	CcSEcCtD
Diphenhydramine—Dizziness—Furosemide—dilated cardiomyopathy	0.00049	0.00591	CcSEcCtD
Diphenhydramine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000489	0.00591	CcSEcCtD
Diphenhydramine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000483	0.00583	CcSEcCtD
Diphenhydramine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000479	0.00578	CcSEcCtD
Diphenhydramine—Constipation—Lisinopril—dilated cardiomyopathy	0.000475	0.00574	CcSEcCtD
Diphenhydramine—Vomiting—Furosemide—dilated cardiomyopathy	0.000471	0.00569	CcSEcCtD
Diphenhydramine—Rash—Furosemide—dilated cardiomyopathy	0.000467	0.00564	CcSEcCtD
Diphenhydramine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000467	0.00563	CcSEcCtD
Diphenhydramine—Headache—Furosemide—dilated cardiomyopathy	0.000464	0.0056	CcSEcCtD
Diphenhydramine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000458	0.00553	CcSEcCtD
Diphenhydramine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000442	0.00533	CcSEcCtD
Diphenhydramine—Nausea—Furosemide—dilated cardiomyopathy	0.00044	0.00531	CcSEcCtD
Diphenhydramine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000399	0.00481	CcSEcCtD
Diphenhydramine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00038	0.00459	CcSEcCtD
Diphenhydramine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000368	0.00444	CcSEcCtD
Diphenhydramine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000354	0.00427	CcSEcCtD
Diphenhydramine—Rash—Lisinopril—dilated cardiomyopathy	0.000351	0.00423	CcSEcCtD
Diphenhydramine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00035	0.00423	CcSEcCtD
Diphenhydramine—Headache—Lisinopril—dilated cardiomyopathy	0.000348	0.0042	CcSEcCtD
Diphenhydramine—Nausea—Lisinopril—dilated cardiomyopathy	0.00033	0.00399	CcSEcCtD
Diphenhydramine—Phenoxybenzamine—ADRB2—dilated cardiomyopathy	0.000251	0.0661	CrCbGaD
Diphenhydramine—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.000171	0.0583	CbGeAlD
Diphenhydramine—CHRM2—heart—dilated cardiomyopathy	0.000165	0.056	CbGeAlD
Diphenhydramine—SLC22A5—myocardium—dilated cardiomyopathy	0.000161	0.0548	CbGeAlD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000149	0.0124	CbGpPWpGaD
Diphenhydramine—HRH1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000148	0.0124	CbGpPWpGaD
Diphenhydramine—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000146	0.0122	CbGpPWpGaD
Diphenhydramine—HRH1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000143	0.0119	CbGpPWpGaD
Diphenhydramine—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000141	0.0117	CbGpPWpGaD
Diphenhydramine—PTGS1—myocardium—dilated cardiomyopathy	0.000126	0.043	CbGeAlD
Diphenhydramine—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000126	0.0105	CbGpPWpGaD
Diphenhydramine—HRH1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00012	0.01	CbGpPWpGaD
Diphenhydramine—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000118	0.00986	CbGpPWpGaD
Diphenhydramine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000116	0.00969	CbGpPWpGaD
Diphenhydramine—SLC22A5—heart—dilated cardiomyopathy	0.000112	0.0382	CbGeAlD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00011	0.00916	CbGpPWpGaD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000107	0.00891	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000106	0.00883	CbGpPWpGaD
Diphenhydramine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	9.84e-05	0.00821	CbGpPWpGaD
Diphenhydramine—CYP2B6—heart—dilated cardiomyopathy	9.75e-05	0.0332	CbGeAlD
Diphenhydramine—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.71e-05	0.0081	CbGpPWpGaD
Diphenhydramine—CYP2C9—heart—dilated cardiomyopathy	9.66e-05	0.0329	CbGeAlD
Diphenhydramine—SLC22A5—cardiac atrium—dilated cardiomyopathy	9.61e-05	0.0327	CbGeAlD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	9e-05	0.00751	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	8.85e-05	0.00739	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	8.82e-05	0.00736	CbGpPWpGaD
Diphenhydramine—PTGS1—heart—dilated cardiomyopathy	8.82e-05	0.03	CbGeAlD
Diphenhydramine—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	8.37e-05	0.00698	CbGpPWpGaD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	8.28e-05	0.00691	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	8.22e-05	0.00686	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	8.09e-05	0.00676	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	8.02e-05	0.0067	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	7.96e-05	0.00664	CbGpPWpGaD
Diphenhydramine—PTGS1—cardiac atrium—dilated cardiomyopathy	7.54e-05	0.0257	CbGeAlD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	7.48e-05	0.00624	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	7.05e-05	0.00588	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	6.76e-05	0.00564	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.66e-05	0.00556	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	6.57e-05	0.00548	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.48e-05	0.00541	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	6.47e-05	0.0054	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	6.3e-05	0.00526	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	6.24e-05	0.00521	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	6.18e-05	0.00515	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.02e-05	0.00503	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.01e-05	0.00501	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.65e-05	0.00471	CbGpPWpGaD
Diphenhydramine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.6e-05	0.00467	CbGpPWpGaD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	5.19e-05	0.00433	CbGpPWpGaD
Diphenhydramine—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.1e-05	0.00426	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	4.54e-05	0.00379	CbGpPWpGaD
Diphenhydramine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	4.36e-05	0.00364	CbGpPWpGaD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	4.29e-05	0.00358	CbGpPWpGaD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	4.21e-05	0.00351	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.19e-05	0.0035	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ANKRD1—dilated cardiomyopathy	4.15e-05	0.00346	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	4.13e-05	0.00345	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.08e-05	0.0034	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.08e-05	0.0034	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	4.01e-05	0.00334	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	4.01e-05	0.00334	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.91e-05	0.00326	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—TAZ—dilated cardiomyopathy	3.9e-05	0.00326	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.8e-05	0.00317	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.8e-05	0.00317	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.79e-05	0.00316	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	3.78e-05	0.00315	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	3.76e-05	0.00314	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	3.72e-05	0.00311	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	3.72e-05	0.0031	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	3.58e-05	0.00299	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.53e-05	0.00295	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—SDHA—dilated cardiomyopathy	3.53e-05	0.00295	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	3.51e-05	0.00293	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.46e-05	0.00289	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	3.46e-05	0.00288	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	3.4e-05	0.00284	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	3.36e-05	0.00281	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	3.35e-05	0.00279	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	3.27e-05	0.00273	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.26e-05	0.00272	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.24e-05	0.0027	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.24e-05	0.0027	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.19e-05	0.00266	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.19e-05	0.00266	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.16e-05	0.00264	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	3.01e-05	0.00251	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.97e-05	0.00248	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	2.96e-05	0.00247	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	2.91e-05	0.00243	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	2.91e-05	0.00242	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	2.87e-05	0.00239	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	2.86e-05	0.00239	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	2.84e-05	0.00237	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	2.76e-05	0.0023	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.76e-05	0.0023	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	2.71e-05	0.00226	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.7e-05	0.00225	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	2.68e-05	0.00223	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	2.64e-05	0.00221	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	2.59e-05	0.00216	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.57e-05	0.00214	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.54e-05	0.00212	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	2.52e-05	0.0021	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.49e-05	0.00208	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.47e-05	0.00206	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.47e-05	0.00206	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	2.45e-05	0.00205	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.45e-05	0.00204	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.43e-05	0.00202	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.43e-05	0.00202	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	2.41e-05	0.00202	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	2.37e-05	0.00197	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.36e-05	0.00197	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	2.34e-05	0.00196	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.32e-05	0.00194	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.29e-05	0.00191	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	2.27e-05	0.0019	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.25e-05	0.00188	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.22e-05	0.00185	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.18e-05	0.00182	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	2.18e-05	0.00182	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	2.17e-05	0.00181	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	2.17e-05	0.00181	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	2.04e-05	0.0017	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.01e-05	0.00168	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	1.95e-05	0.00162	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	1.95e-05	0.00162	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	1.92e-05	0.0016	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	1.9e-05	0.00158	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.87e-05	0.00156	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	1.87e-05	0.00156	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	1.85e-05	0.00155	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	1.85e-05	0.00155	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.8e-05	0.0015	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.77e-05	0.00148	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.75e-05	0.00146	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	1.74e-05	0.00145	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.72e-05	0.00144	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	1.64e-05	0.00137	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.54e-05	0.00129	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	1.54e-05	0.00128	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	1.49e-05	0.00124	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.45e-05	0.00121	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	1.43e-05	0.0012	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.42e-05	0.00118	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.41e-05	0.00117	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.39e-05	0.00116	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.39e-05	0.00116	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.39e-05	0.00116	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.37e-05	0.00114	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.37e-05	0.00114	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.36e-05	0.00114	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.35e-05	0.00113	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	1.33e-05	0.00111	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.33e-05	0.00111	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.32e-05	0.0011	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.31e-05	0.0011	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	1.31e-05	0.0011	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.31e-05	0.00109	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.3e-05	0.00108	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.27e-05	0.00106	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.27e-05	0.00106	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.27e-05	0.00106	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.25e-05	0.00105	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.24e-05	0.00104	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.24e-05	0.00104	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.23e-05	0.00103	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.22e-05	0.00102	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.21e-05	0.00101	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.2e-05	0.001	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.2e-05	0.000998	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.18e-05	0.000981	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.16e-05	0.000966	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.14e-05	0.00095	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.13e-05	0.000943	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	1.13e-05	0.000939	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.12e-05	0.000935	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.07e-05	0.000894	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.05e-05	0.00088	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.02e-05	0.000853	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.02e-05	0.000848	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1e-05	0.000834	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.73e-06	0.000812	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	9.59e-06	0.0008	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.57e-06	0.000799	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	9.34e-06	0.000779	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.23e-06	0.00077	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.08e-06	0.000758	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.42e-06	0.000702	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	8.41e-06	0.000702	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.28e-06	0.000691	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.27e-06	0.00069	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8e-06	0.000668	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.89e-06	0.000658	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.79e-06	0.00065	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.76e-06	0.000648	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.71e-06	0.000643	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.54e-06	0.000629	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.47e-06	0.000624	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.47e-06	0.000624	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.42e-06	0.000619	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.35e-06	0.000614	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.35e-06	0.000614	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.29e-06	0.000609	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.16e-06	0.000598	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.1e-06	0.000593	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.05e-06	0.000588	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.01e-06	0.000585	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.95e-06	0.00058	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.85e-06	0.000571	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.84e-06	0.00057	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.74e-06	0.000562	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.73e-06	0.000561	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.62e-06	0.000552	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.4e-06	0.000534	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	6.36e-06	0.000531	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.23e-06	0.00052	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	6.2e-06	0.000517	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	6.18e-06	0.000516	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.07e-06	0.000507	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CD36—dilated cardiomyopathy	6.02e-06	0.000502	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	5.93e-06	0.000495	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	5.78e-06	0.000482	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.75e-06	0.00048	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.65e-06	0.000472	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	5.58e-06	0.000466	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.47e-06	0.000456	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.45e-06	0.000455	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AGT—dilated cardiomyopathy	5.42e-06	0.000452	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.36e-06	0.000448	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	5.2e-06	0.000434	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.75e-06	0.000396	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	4.71e-06	0.000393	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.68e-06	0.000391	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.67e-06	0.00039	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.61e-06	0.000385	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	4.59e-06	0.000383	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.23e-06	0.000353	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.16e-06	0.000348	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	4.13e-06	0.000345	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	4.04e-06	0.000337	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	3.98e-06	0.000332	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.56e-06	0.000297	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.47e-06	0.00029	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.28e-06	0.000273	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.26e-06	0.000272	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.25e-06	0.000271	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.21e-06	0.000267	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.19e-06	0.000266	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.16e-06	0.000264	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.12e-06	0.000261	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.87e-06	0.00024	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.85e-06	0.000238	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.81e-06	0.000234	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.78e-06	0.000232	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.76e-06	0.00023	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.7e-06	0.000226	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.43e-06	0.000203	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.92e-06	0.000161	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.89e-06	0.000158	CbGpPWpGaD
